Analyst Price Target is $1.43
▲ +35.22% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for MultiPlan in the last 3 months. The average price target is $1.43, with a high forecast of $2.05 and a low forecast of $1.00. The average price target represents a 35.22% upside from the last price of $1.06.
Current Consensus is
The current consensus among 3 contributing investment analysts is to hold stock in MultiPlan. This rating has held steady since April 2022, when it changed from a Buy consensus rating.
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment and revenue integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.